IRVINE, Calif., May 5, 2020 /PRNewswire/ -- Edwards Lifesciences
Corporation (NYSE: EW), the global leader in patient-focused
innovations for structural heart disease and critical care
monitoring, is scheduled to participate in two upcoming investor
conferences.
On May 13, 2020, Scott B. Ullem, chief financial officer, is
scheduled to present at the Bank of America Virtual Healthcare
Conference at 5:00 p.m. ET.
On May 19, 2020, Ullem is
scheduled to present at the UBS Virtual Healthcare Conference at
11:40 a.m. ET.
A live webcast of the presentations will be available to all
interested parties on the Edwards Lifesciences investor relations
website at http://ir.edwards.com/. An archived version of the
webcast will be available a few hours following the completion of
each event on the Edwards investor relations website.
About Edwards Lifesciences
Edwards Lifesciences, based in Irvine,
Calif., is the global leader of patient-focused medical
innovations for structural heart disease and critical care
monitoring. We are driven by a passion for patients, dedicated to
improving and enhancing lives through partnerships with clinicians
and stakeholders across the global healthcare landscape. For more
information, visit Edwards.com and follow us on Facebook,
Instagram, LinkedIn, Twitter and YouTube.
Edwards, Edwards Lifesciences and the stylized E logo are
trademarks of Edwards Lifesciences Corporation and its affiliates.
All other trademarks are the property of their respective owners.
This statement is made on behalf of Edwards Lifesciences
Corporation and its subsidiaries.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/edwards-lifesciences-announces-may-2020-investor-conference-schedule-301052661.html
SOURCE Edwards Lifesciences Corporation